CCAR1
Basic information
Region (hg38): 10:68721012-68792377
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCAR1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 32 | 33 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 33 | 1 | 0 |
Variants in CCAR1
This is a list of pathogenic ClinVar variants found in the CCAR1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-68736923-A-G | not specified | Uncertain significance (Aug 24, 2023) | ||
10-68742508-G-A | not specified | Uncertain significance (Apr 05, 2023) | ||
10-68747408-C-G | not specified | Uncertain significance (Jun 16, 2024) | ||
10-68747493-G-C | not specified | Uncertain significance (Dec 27, 2023) | ||
10-68749174-C-T | not specified | Uncertain significance (Aug 05, 2023) | ||
10-68749208-G-A | not specified | Uncertain significance (Mar 29, 2024) | ||
10-68749601-G-A | not specified | Uncertain significance (Jun 28, 2022) | ||
10-68749624-C-T | not specified | Uncertain significance (May 08, 2023) | ||
10-68749637-G-T | not specified | Uncertain significance (Mar 20, 2024) | ||
10-68753854-C-T | not specified | Uncertain significance (Apr 17, 2023) | ||
10-68753857-G-T | not specified | Uncertain significance (Oct 14, 2023) | ||
10-68753866-T-C | not specified | Uncertain significance (Jul 20, 2021) | ||
10-68753884-G-A | not specified | Uncertain significance (Jul 13, 2021) | ||
10-68754070-G-A | not specified | Uncertain significance (Sep 28, 2022) | ||
10-68754730-G-C | not specified | Uncertain significance (Jul 19, 2023) | ||
10-68754793-G-A | not specified | Uncertain significance (Apr 28, 2022) | ||
10-68755520-A-T | not specified | Uncertain significance (Sep 26, 2023) | ||
10-68755521-G-A | not specified | Uncertain significance (May 24, 2023) | ||
10-68756465-G-T | not specified | Uncertain significance (Oct 20, 2021) | ||
10-68761124-A-G | not specified | Uncertain significance (Jan 10, 2023) | ||
10-68761162-T-A | not specified | Likely benign (Mar 01, 2023) | ||
10-68765961-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
10-68771338-A-G | not specified | Uncertain significance (Jul 26, 2022) | ||
10-68771387-C-T | not specified | Uncertain significance (May 05, 2023) | ||
10-68773046-A-C | not specified | Uncertain significance (Mar 29, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCAR1 | protein_coding | protein_coding | ENST00000265872 | 24 | 71366 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000655 | 125728 | 0 | 18 | 125746 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.64 | 353 | 605 | 0.584 | 0.0000323 | 7540 |
Missense in Polyphen | 81 | 187.5 | 0.43201 | 2022 | ||
Synonymous | 1.55 | 177 | 205 | 0.862 | 0.0000101 | 2086 |
Loss of Function | 6.95 | 9 | 73.1 | 0.123 | 0.00000425 | 833 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000125 | 0.000123 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000231 | 0.000231 |
European (Non-Finnish) | 0.0000819 | 0.0000791 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000656 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Associates with components of the Mediator and p160 coactivator complexes that play a role as intermediaries transducing regulatory signals from upstream transcriptional activator proteins to basal transcription machinery at the core promoter. Recruited to endogenous nuclear receptor target genes in response to the appropriate hormone. Also functions as a p53 coactivator. May thus play an important role in transcriptional regulation (By similarity). May be involved in apoptosis signaling in the presence of the reinoid CD437. Apoptosis induction involves sequestration of 14-3-3 protein(s) and mediated altered expression of multiple cell cycle regulatory genes including MYC, CCNB1 and CDKN1A. Plays a role in cell cycle progression and/or cell proliferation (PubMed:12816952). In association with CALCOCO1 enhances GATA1- and MED1-mediated transcriptional activation from the gamma-globin promoter during erythroid differentiation of K562 erythroleukemia cells (PubMed:24245781). Can act as a both a coactivator and corepressor of AR-mediated transcription. Contributes to chromatin looping and AR transcription complex assembly by stabilizing AR-GATA2 association on chromatin and facilitating MED1 and RNA polymerase II recruitment to AR-binding sites. May play an important role in the growth and tumorigenesis of prostate cancer cells (PubMed:23887938). {ECO:0000250|UniProtKB:Q8CH18, ECO:0000269|PubMed:12816952, ECO:0000269|PubMed:23887938, ECO:0000269|PubMed:24245781}.;
- Pathway
- Metabolism of RNA;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA
(Consensus)
Recessive Scores
- pRec
- 0.159
Intolerance Scores
- loftool
- 0.584
- rvis_EVS
- -1.09
- rvis_percentile_EVS
- 7.11
Haploinsufficiency Scores
- pHI
- 0.686
- hipred
- Y
- hipred_score
- 0.639
- ghis
- 0.696
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.816
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ccar1
- Phenotype
Gene ontology
- Biological process
- mRNA splicing, via spliceosome;regulation of transcription, DNA-templated;apoptotic process;cell cycle;positive regulation of cell population proliferation;positive regulation of cell migration;negative regulation of nucleic acid-templated transcription;positive regulation of nucleic acid-templated transcription
- Cellular component
- nucleus;nucleoplasm;perinuclear region of cytoplasm
- Molecular function
- RNA polymerase II distal enhancer sequence-specific DNA binding;transcription coactivator activity;transcription corepressor activity;RNA binding;protein binding;nuclear receptor transcription coactivator activity